Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Alexion Pharmaceuticals, Inc.

MA, United States

CMS manufacturer 100000005462

Open in the dashboard

General payments

$67,224,221

239,092 payments

Research payments

$115,199,600

9,380 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Alexion Pharmaceuticals, Inc. reported paying $67,224,221 in general payments and $115,199,600 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $15,677,235 38,163
2025 Research $23,660,771 705
2024 General $12,486,440 46,611
2024 Research $22,187,637 618
2023 General $10,805,437 40,042
2023 Research $25,366,524 657
2022 General $7,274,151 36,689
2022 Research $15,539,657 541
2021 General $7,444,700 26,474
2021 Research $14,271,202 2,898
2020 General $4,591,824 14,474
2020 Research $8,821,723 1,859
2019 General $8,944,435 36,639
2019 Research $5,352,085 2,102

Breakdown

Top recipients General payments · program year 2025
  1. Rady Childrens Hospital - San Diego Teaching hospital · CA $5,510,000 3 payments
  2. National Jewish Health Teaching hospital · CO $339,716 34 payments
  3. Brigham And Womens Hospital Teaching hospital · MA $250,840 8 payments
  4. Steven Petak Endocrinology, Diabetes & Metabolism · Houston, TX $127,104 200 payments
  5. Perry Shieh Neurology · Los Angeles, CA $125,670 177 payments
  6. Zsila Sadighi Neurology · Houston, TX $125,618 185 payments
  7. Tuan Vu Neurology · Tampa, FL $117,707 128 payments
  8. Eric Rush Clinical Genetics (M.D.) · Kansas City, MO $114,229 104 payments
  9. Daniel Long Neurology · Neenah, WI $100,089 81 payments
  10. Christopher Scheiner Neurology · Dayton, OH $85,992 82 payments
Top research recipients Research payments · program year 2025
  1. Brigham And Womens Hospital Teaching hospital · MA $2,442,020 11 payments
  2. Vanderbilt University Medical Center Teaching hospital · TN $1,800,229 12 payments
  3. Ut Southwestern Medical Center At Dallas $783,160 6 payments
  4. Trustees of Columbia University $680,020 4 payments
  5. Washington University In Saint Louis $652,163 7 payments
  6. Ohio State University Research Compliance $643,272 14 payments
  7. U Of U Hospitals & Clinics Teaching hospital · UT $579,526 9 payments
  8. Cleveland Clinic Hospital Teaching hospital · OH $571,656 7 payments
  9. Duke University School Of Medicine Office Of Continuing Medical Education $491,620 12 payments
  10. Langley Porter Psychiatric Hospital Teaching hospital · CA $446,441 5 payments
Products the payments named General payments · program year 2025
  1. Ultomiris Rare Disease $4,444,569 75% · 10,670 recipients
  2. Strensiq Rare Disease $668,722 11% · 3,839 recipients
  3. Koselugo Oncology $634,876 11% · 950 recipients
  4. Soliris Rare Disease $180,694 3% · 233 recipients
  5. Kanuma Rare Disease $6,945 <1% · 1 recipient

The top 5 of 6 products; each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2025
  1. Neurology Psychiatry & Neurology $3,234,367 37% · 2,380 practitioners
  2. Nephrology Internal Medicine $770,384 9% · 879 practitioners
  3. Pediatric Hematology-Oncology Pediatrics $480,130 6% · 155 practitioners
  4. Hematology & Oncology Internal Medicine $426,466 5% · 1,050 practitioners
  5. Endocrinology, Diabetes & Metabolism Internal Medicine $403,761 5% · 855 practitioners

The top 5 of 202 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $6,894,713 44% · 1,486 recipients
  2. Massachusetts $811,649 5% · 217 recipients
  3. Texas $727,165 5% · 1,432 recipients
  4. Florida $698,804 4% · 1,621 recipients
  5. New York $541,588 3% · 1,159 recipients

The top 5 of 52 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $35,760,845 11,779 payments
  2. Consulting Fee $13,147,404 4,498 payments
  3. Food and Beverage $6,704,270 202,019 payments
  4. Travel and Lodging $4,901,546 15,771 payments
  5. Space rental or facility fees (teaching hospital only) $2,706,042 753 payments
  6. Royalty or License $2,208,595 55 payments
  7. Grant $807,442 24 payments
  8. Gift $298,672 90 payments
  9. Education $292,298 3,264 payments
  10. Charitable Contribution $290,929 140 payments
239,092 general · 9,380 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record